Latest return on equity
Aligos Therapeutics, Inc. Return on equity
Aligos Therapeutics, Inc. (ALGS) return on equity with its verified observation…
Direct answer
Aligos Therapeutics, Inc.'s return on equity is -113.59%.
The verified market snapshot reports -113.59%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 14, 2026.
Get free Aligos Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -113.59%
Explore related company data
View Aligos Therapeutics, Inc.'s market capitalizationView Aligos Therapeutics, Inc.'s price-to-book ratioView Aligos Therapeutics, Inc.'s 52-week price rangeView Aligos Therapeutics, Inc.'s revenue growthView Aligos Therapeutics, Inc.'s profit marginView Aligos Therapeutics, Inc.'s debt-to-equity ratioView all Aligos Therapeutics, Inc. key metricsReturn to Aligos Therapeutics, Inc. profile